He has also participated in the construction of commercial organizations in newer ventures – The Urotech Division of Biocompatibles International, Tissuemed, SIRTeX Medical and as CEO of Parafricta.


He currently has his own consultancy, Quintain Medical Ltd., working with medical technology companies and innovation organisations.

In addition, he was on the Selection Panel for the NIHR i4i Product Development grant awards for 6 years.